Clinical Trial Update: Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating glufosfamide, with or without hydration, in patients with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Glufosfamide (glufosfamide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED